These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33950465)

  • 1. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
    Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
    Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Busschbach J; Luo N
    Eur J Health Econ; 2024 Nov; 25(8):1361-1370. PubMed ID: 38356007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
    Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
    van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
    Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
    Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
    Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitioning between the EQ-5D youth and adult descriptive systems in a group of adolescents.
    Verstraete J; Kind P; Janssen MF; Yang Z; Stolk E; Gebregziabiher A
    J Patient Rep Outcomes; 2024 Aug; 8(1):93. PubMed ID: 39133433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Investigation of Inter-Rater and Intra-Proxy Agreement in Measuring Quality of Life of Children in the Community Using the EQ-5D-Y-3L.
    Khanna D; Khadka J; Mpundu-Kaambwa C; Chen G; Dalziel K; Devlin N; Ratcliffe J;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):113-128. PubMed ID: 38280125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
    Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
    Verstraete J; Amien R; Scott D
    Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients.
    Zhang H; Liu B; Gu W; Cao Y; Xu J; Tan RL; Chang E; Zheng W; Li H; Zhou L; Jia Y; Yang H; Guo S; Huang W; Luo N
    Support Care Cancer; 2023 Dec; 32(1):14. PubMed ID: 38060009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom.
    Long D; Polinder S; Bonsel GJ; Haagsma JA
    Qual Life Res; 2021 Oct; 30(10):2961-2971. PubMed ID: 34075530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
    O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Proxy-Reported EQ-5D-3L-Y and Its Agreement in Self-reported EQ-5D-3L-Y for Patients With Adolescent Idiopathic Scoliosis.
    Lin J; Wong CKH; Cheung PWH; Luo N; Cheung JPY
    Spine (Phila Pa 1976); 2020 Jul; 45(13):E799-E807. PubMed ID: 32539293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.